BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

5144 related articles for article (PubMed ID: 3926559)

  • 1. Stimulation of S91 melanoma tyrosinase activity by superpotent alpha-melanotropins.
    Marwan MM; Abdel Malek ZA; Kreutzfeld KL; Hadley ME; Wilkes BC; Hruby VJ; Castrucci AM
    Mol Cell Endocrinol; 1985 Jul; 41(2-3):171-7. PubMed ID: 3926559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prolonged stimulation of S91 melanoma tyrosinase by [Nle4, D-Phe7]-substituted alpha-melanotropins.
    Abdel Malek ZA; Kreutzfeld KL; Marwan MM; Hadley ME; Hruby VJ; Wilkes BC
    Cancer Res; 1985 Oct; 45(10):4735-40. PubMed ID: 2992767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Nle4, D-Phe7]-alpha-MSH: a superpotent melanotropin that "irreversibly" activates melanoma tyrosinase.
    Hadley ME; Abdel Malek ZA; Marwan MM; Kreutzfeld KL; Hruby VJ
    Endocr Res; 1985; 11(3-4):157-70. PubMed ID: 3009169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term and residual melanotropin-stimulated tyrosinase activity in S91 melanoma cells is density dependent.
    Abdel Malek ZA; Kreutzfeld KL; Hadley ME; Bregman MD; Hruby VJ; Meyskens FL
    In Vitro Cell Dev Biol; 1986 Feb; 22(2):75-81. PubMed ID: 3081484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potent and prolonged melanotropic activities of the alpha-MSH fragment analog, Ac-[Nle4,D-Phe7]-alpha-MSH4-9-NH2.
    Klemes DG; Kreutzfeld KL; Hadley ME; Cody WL; Hruby VJ
    Biochem Biophys Res Commun; 1986 Jun; 137(2):722-8. PubMed ID: 3089218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and biological actions of highly potent and prolonged acting biotin-labeled melanotropins.
    Chaturvedi DN; Knittel JJ; Hruby VJ; Castrucci AM; Hadley ME
    J Med Chem; 1984 Nov; 27(11):1406-10. PubMed ID: 6436488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potent and prolonged acting cyclic lactam analogues of alpha-melanotropin: design based on molecular dynamics.
    Al-Obeidi F; Castrucci AM; Hadley ME; Hruby VJ
    J Med Chem; 1989 Dec; 32(12):2555-61. PubMed ID: 2555512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and actions of a melanotropin conjugate, Ac-[Nle4, Glu(gamma-4'-hydroxyanilide)5, D-Phe7]alpha-MSH4-10-NH2, on melanocytes and melanoma cells in vitro.
    al-Obeidi F; Mulcahy M; Pitt VS; Begay V; Hadley ME; Hruby VJ
    J Pharm Sci; 1990 Jun; 79(6):500-4. PubMed ID: 2168479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclic lactam alpha-melanotropin analogues of Ac-Nle4-cyclo[Asp5, D-Phe7,Lys10] alpha-melanocyte-stimulating hormone-(4-10)-NH2 with bulky aromatic amino acids at position 7 show high antagonist potency and selectivity at specific melanocortin receptors.
    Hruby VJ; Lu D; Sharma SD; Castrucci AL; Kesterson RA; al-Obeidi FA; Hadley ME; Cone RD
    J Med Chem; 1995 Sep; 38(18):3454-61. PubMed ID: 7658432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 4-Norleucine, 7-D-phenylalanine-alpha-melanocyte-stimulating hormone: a highly potent alpha-melanotropin with ultralong biological activity.
    Sawyer TK; Sanfilippo PJ; Hruby VJ; Engel MH; Heward CB; Burnett JB; Hadley ME
    Proc Natl Acad Sci U S A; 1980 Oct; 77(10):5754-8. PubMed ID: 6777774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclic lactam analogues of Ac-[Nle4]alpha-MSH4-11-NH2.
    Sugg EE; Castrucci AM; Hadley ME; van Binst G; Hruby VJ
    Biochemistry; 1988 Oct; 27(21):8181-8. PubMed ID: 2852955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and biological evaluation of the superagonist [N alpha-chlorotriazinylaminofluorescein-Ser1,Nle4,D-Phe7]-al pha-MSH.
    Chaturvedi DN; Hruby VJ; Castrucci AM; Kreutzfeld KL; Hadley ME
    J Pharm Sci; 1985 Mar; 74(3):237-40. PubMed ID: 2989482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative biological activities of potent active-site analogues of alpha-melanotropin. Effect of tyrosine substitution at position-4.
    Wilkes BC; Sawyer TK; Hruby VJ; Hadley ME
    Int J Pept Protein Res; 1984 Jun; 23(6):621-9. PubMed ID: 6332085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alpha-melanocyte-stimulating hormone regulation of tyrosinase in Cloudman S-91 mouse melanoma cell cultures.
    Fuller BB; Lunsford JB; Iman DS
    J Biol Chem; 1987 Mar; 262(9):4024-33. PubMed ID: 3031058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclic melanotropins. 5. Importance of the C-terminal tripeptide (Lys-Pro-Val).
    Cody WL; Wilkes BC; Muska BJ; Hruby VJ; Castrucci AM; Hadley ME
    J Med Chem; 1984 Sep; 27(9):1186-90. PubMed ID: 6332195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The melanotropic peptide, [Nle4,D-Phe7] alpha-MSH, stimulates human melanoma tyrosinase activity and inhibits cell proliferation.
    Jiang J; Sharma SD; Nakamura S; Lai JY; Fink JL; Hruby VJ; Hadley ME
    Pigment Cell Res; 1995 Dec; 8(6):314-23. PubMed ID: 8789740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Linear and cyclic alpha-melanotropin [4-10]-fragment analogues that exhibit superpotency and residual activity.
    Hadley ME; Marwan MM; al-Obeidi F; Hruby VJ; Castrucci AM
    Pigment Cell Res; 1989; 2(6):478-84. PubMed ID: 2557603
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis of tritium labeled Ac-[Nle4, D-Phe7]-alpha-MSH4-11-NH2: a superpotent melanotropin with prolonged biological activity.
    Wilkes BC; Hruby VJ; Yamamura HI; Akiyama K; Castrucci AM; Hadley ME; Andrews JR; Wan YP
    Life Sci; 1984 Mar; 34(10):977-84. PubMed ID: 6608041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biological activity, binding, and metabolic fate of Ac-[Nle4, D-Phe7]alpha-MSH4-11NH2 with the F1 variant of B16 melanoma cells.
    Panasci LC; McQuillan A; Kaufman M
    J Cell Physiol; 1987 Jul; 132(1):97-103. PubMed ID: 3110178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of pro-opiomelanocortin peptides on cyclic AMP and tyrosinase in melanoma cells.
    Farah JM; Bishop JF; Nguyen HQ; O'Donohue TL
    Peptides; 1986; 7(3):437-41. PubMed ID: 3022251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 258.